Quantitative analysis for Aurora Cannabis Inc. (ACB) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (58.0) (grade B). Gem alpha score: 35.0. 34 signals analyzed (28 differentiated alt-data).
ACB stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-30 | $3.46 | $3.30 | $3.44 |
| 2026-05-12 | $3.43 | $3.32 | $3.36 |
| 2026-05-22 | $3.60 | $3.46 | $3.46 |
| 2026-06-04 | $3.61 | $3.43 | $3.51 |
| 2026-06-16 | $3.04 | $2.91 | $3.00 |
| 2026-06-29 | $2.89 | $2.81 | $2.88 |
| 2026-07-10 | $2.73 | $2.67 | $2.71 |
| 2026-07-22 | $2.71 | $2.65 | $2.66 |
| 2026-08-03 | $2.86 | $2.79 | $2.83 |
| 2026-08-13 | $3.92 | $3.72 | $3.79 |
| 2026-08-25 | $4.06 | $3.88 | $4.01 |
| 2026-09-04 | $3.97 | $3.86 | $3.95 |
How Aurora Cannabis Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| CRBU | Caribou Biosciences, Inc. | $198M | — |
| IPSC | Century Therapeutics, Inc. | $195M | — |
| ARTV | Artiva Biotherapeutics, Inc. | $194M | 66.0 |
| NBP | NovaBridge Biosciences | $203M | — |
View all Health Care stocks by valuation and signals →
Aurora Cannabis Inc. (ACB) scores Buy (58.0), and the composite conceals a 69-point disagreement between its dimensions. It is strongest on ML forecast at 83 and valuation at 72, and weakest on social sentiment at 16 and analyst consensus at 14. A stock can carry ML forecast that high while analyst consensus sits at 14; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| ML forecast | 83 |
| valuation | 72 |
| competitive moat | 55 |
| technicals | 44 |
| AI Alpha (gem) | 33 |
| social sentiment | 16 |
| analyst consensus | 14 |
StoQuant analyzes 34 signals (28 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Aurora Cannabis Inc. (ACB): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/ACB"><img src="https://stoquant.com/badge/ACB.svg" alt="Aurora Cannabis Inc. (ACB) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.